abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

內容有以下的語言版本: English, 日本語

故事

2021年8月17日

USA: Civil society calls on SEC & other stakeholders to halt technology company Cellebrite going public until human rights compliance demonstrated

Civil society organisations including Access Now and the Committee to Protect Journalists have recorded human rights risks and abuses linked to technology made by Cellebrite, an Israeli digital intelligence firm. In April 2021 Cellebrite announced its intention to become a public company, by entering into an agreement with a special-purpose acquisition company (or SPAC) named TWC Tech Holdings II Corp., which will allow it to be listed on the NASDAQ stock exchange and expand its opportunities for growth.

Alarmed at this deal, in July 2021 a group of civil society organizations and individuals wrote a letter urging the U.S. Securities and Exchange Commission (the SEC), NASDAQ, and other stakeholders to stop the process until Cellebrite demonstrates its commitment to safeguarding human rights. The call follows pressure on key stakeholders from U.S. Member of Congress, Tom Malinowski, due to “urgent concern over unresolved human rights risks linked to the sales history of Cellebrite.”

The Business & Human Rights Resource Centre subsequently raised the letter again with the SEC, Nasdaq, various investors and shareholders linked to the Cellebrite's bid to go public, and invited them to respond to its concerns and recommendations. After we contacted these actors, Cellebrite announced its Registration Statement on Form F-4 has been declared effective by the SEC, but we continued to seek comments on the human rights risks associated with the company’s technologies. None of the stakeholders responded to the request.

企業回應

683 Capital Management, LLC

沒有回應

Citadel LLC

沒有回應

Crescent Park Management, L.P.

沒有回應

Crosslink Capital

沒有回應

Empyrean Capital Partners, LP

沒有回應

Phoenix Holdings Ltd

沒有回應

Glazer Capital, LLC

沒有回應

Light Street Capital Management, LLC

沒有回應

Makena Capital Management

沒有回應

Migdal SAL

沒有回應

Millennium Management LLC

沒有回應

Nasdaq

沒有回應

Park West Asset Management LLC

沒有回應

U.S. Securities and Exchange Commission (SEC)

沒有回應

Weiss Asset Management LP

沒有回應

West Coast Equity Partners LLC

沒有回應

Axon Enterprise, Inc.

沒有回應

時間線

隱私資訊

本網站使用 cookie 和其他網絡存儲技術。您可以在下方設置您的隱私選項。您所作的更改將立即生效。

有關我們使用網絡儲存技術的更多資訊,請參閱我們的 數據使用和 Cookie 政策

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

分析cookie

ON
OFF

您瀏覽本網頁時我們將以Google Analytics收集信息。接受此cookie將有助我們理解您的瀏覽資訊,並協助我們改善呈現資訊的方法。所有分析資訊都以匿名方式收集,我們並不能用相關資訊得到您的個人信息。谷歌在所有主要瀏覽器中都提供退出Google Analytics的添加應用程式。

市場營銷cookies

ON
OFF

我們從第三方網站獲得企業責任資訊,當中包括社交媒體和搜尋引擎。這些cookie協助我們理解相關瀏覽數據。

您在此網站上的隱私選項

本網站使用 cookie 和其他網絡儲存技術來增強您在必要核心功能之外的體驗。